Generate Biomedicines Inc at Goldman Sachs Healthcare Conference Transcript
Good afternoon. Thank you, everyone, for joining us. Really pleased to have with us the Generate team. With us, we have Michael Nally, CEO; and Jason Silver, CFO.
Questions & Answers
To start here, Mike, would you introduce Generate, your platform, your clinical programs, and the catalyst path for the next 12 to 18 months?
Yeah, thanks, Salveen. It's great to be here and excited to share a little bit more about Generate and the story. So Generate is a company that was founded in 2018 with a fundamental premise that a data-driven approach to protein design could lead to superior outcomes.
At the time, the prevailing paradigm was largely biophysical-based tools to design proteins. And it was a convergence moment in the field where the transformer paper was coming out of Google at that point. We saw massive increases in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
